GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...

Vaccine manufacturer GSK plans to invest $800 million in its Lancaster County facility, creating 200 new jobs and expanding its manufacturing and R&D capabilities.

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

Last week, GlaxoSmithKline and Northwestern University filed separate lawsuits against Moderna, accusing its mRNA-based vaccines of ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

Global biopharma company GSK is investing up to $800 million in Pennsylvania and expanding its facility in Lancaster County.

Despite strong cash flow and organic growth in most of its key brands, high leverage and mixed valuation ratios lead to a ...